Canadian Memorial Chiropractic College

Toronto, Canada

Canadian Memorial Chiropractic College

Toronto, Canada
SEARCH FILTERS
Time filter
Source Type

News Article | May 15, 2017
Site: globenewswire.com

BELLEVUE, Wash., May 15, 2017 (GLOBE NEWSWIRE) -- Turbine Truck Engines, Inc. (OTCQB:TTEG) (“TTE” or the “Company”) announced today that, effective May 9, 2017, Enzo Cirillo has resigned his position as the Company’s Chairman of the Board, a member of the Board of Directors and Interim Chief Executive Officer, Christopher David has resigned his position as the Company’s Secretary and Treasurer and that Judith Norstrud has resigned her position as the Company’s Principal Financial Officer and Principal Accounting Officer. Mr. David retains his responsibilities as the Company’s President and as a member of the Company’s Board of Directors. The Company also announced that the TTE Board of Directors has increased the size of the Company’s Board to three members and appointed Dr. Pierre Dalcourt, D.C. and Mr. Michael Gaynor as directors, effective May 9, 2017. The Company also announced today that, effective May 9, 2017, the TTE Board of Directors has appointed Ms. Klara Radulyne, CPA as the Company’s Principal Financial Officer. Chris David, TTE’s President and a Board Director, stated: “The new Board of Directors wishes to thank Mr. Cirillo and Ms. Norstrud for their valuable contributions to TTE. Since his arrival as the Company’s Interim CEO and Board Chairman in August 2014, Enzo has played a critically important role in strengthening TTE's balance sheet, increasing shareholder value and completing the acquisition of Novo Healthnet Limited.  The newly appointed Board members and PFO provide TTE with exceptional talent and expertise as the Company undertakes implementing the Novo growth model to provide effective and efficient whole health medicine through the integration of healthcare, technology and medical science.” Enzo Cirillo stated: “I am grateful for the support I have received from the shareholders, Board of Directors and management of TTE over the time I have served as TTE’s Interim CEO and Board Chairman. I wish the new team all the best in bringing the Novo comprehensive healthcare and wellness platform to market.” Biographies of each of the new Board members and the new PFO are as follows: As a chiropractic business owner, with a core focus and passion serving the masses with a patient centered model, Dr. Dalcourt has had great success creating scalable businesses and high volume practices combining the wellness approach with sound science. Dr. Dalcourt is a professional health coach and speaker on various stages across North America, as well as a best-selling author having co-written several books on chiropractic, health and self-improvement. In 1994, Dr. Dalcourt graduated Magna Cum Laude from Canadian Memorial Chiropractic College, Toronto, Ontario. He is a certified acupuncturist, having received his certification from the Medecina Alternativa Institute of Sri Lanka. For over 28 years as a healthcare professional and business owner, Mr. Gaynor prides himself on his passion to deliver a healthcare model that includes best practices and innovation to meet various needs for both his community and his patients. At the core of Mr. Gaynor’s mission is building strong relationships, trust, and rapport which cultivates long-term partnerships, alliances, collaboration, forward momentum and positive results. In 1994, Mr. Gaynor founded Back on Track Physiotherapy & Health Centres which has grown into 8 multidisciplinary health and wellness centres of excellence across eastern Ontario. During these 23 years, Mr. Gaynor has proven his capacity to simultaneously practice his healthcare professional trade while also being responsible for business development, marketing and operations. The Back on Track expansion model has been centered on organic business development combined with turnarounds and transitional growth via clinic acquisitions and strategic partnerships. In 2013, Back on Track was acquired by Novo Healthnet Limited (“Novo”). Mr. Gaynor joined the Novo team as managing partner and Chief Operating Officer. Currently, Mr. Gaynor is an integral contributor to Novo’s strategic planning, ongoing growth and business development. In 1989, Mr. Gaynor graduated from Queen’s University in 1989 with a Bachelor of Science in Physical Therapy. Mr. Gaynor has undertaken numerous post graduate studies in a variety of areas including manual therapy, orthopaedics, sports medicine, rehabilitation exercise, acupuncture, as well as practice management and business development, and is committed to the continuing education process. In 1999, as a Fellow of the Canadian Academy Manipulative Physiotherapists (CAMPT), Mr. Gaynor received his Diploma of Advanced Manual & Manipulative Physiotherapy from the Canadian Physiotherapy Association (CPA).  He has been an assistant instructor in post-graduate studies for physiotherapists within the Orthopaedic Division of the CPA and was the former president of the national capital district of the CPA’s orthopaedic division. Klara Radulyne is the Director of Finance for Novo managing all accounting and finance functions. In addition, Ms. Radulyne is TTE’s Principal Financial Officer managing all internal and external reporting functions including process optimization, strategic planning and regulatory compliance. In 2000, Ms. Radulyne acquired her Masters Degree in Accounting and Corporate Valuation from Corvinus University, Budapest, Hungary and immediately commenced her accounting career as a management accountant in a Hungarian utilities industry company. Ms. Radulyne moved to Canada and began her employment with Novo Healthnet Limited in 2006 as a Junior Accountant. Ms. Radulyne earned her Canadian CGA designation in 2010 and Canadian CPA designation in 2014. Since 2000, TTE has been a clean-air technology company dedicated to identifying, developing and commercializing important scientific innovations designed to enhance both environmental conservation and cost savings in how the world produces and consumes energy. With the Novo acquisition, effective May 9, 2017, TTE immediately re-directed all business operations away from the alternative energy sector and now focuses its resources and operations toward executing the Novo growth model to provide effective and efficient whole health medicine through the integration of healthcare, technology and medical science. For more information concerning TTE, please visit www.ttengines.com. Novo is a wholly owned foreign subsidiary of TTE. Novo owns a 100% stake in Novo Assessments, Inc., Novo Healthnet Rehab Limited and Novo Peak Health, Inc., and an 80% stake in Novo Healthnet Kemptville Centre, Inc. (collectively the “Novo Family”) all of which are Ontario province, Canada corporations. The Novo Family operates within the healthcare para-medical services sector. With physical presence in over 350 locations and expanding, the Novo Family’s network provides healthcare treatment and services to more than 350,000 patients annually in clinic, home and institutional environments. Novo’s future growth strategy is centered on expanding patient based healthcare solutions through the integration of healthcare, technology and medical science. Through an advanced virtual physician access system, Novo’s integrated healthcare platform will present patients worldwide with one-center, patient-based healthcare diagnostic and treatment solutions without compromising the traditional primary care physician platform. Novo’s emphasis on providing access to primary care medical solutions through virtual technology allows for centralization of services to occur on a micro footprint level while providing healthcare solutions to remote and small population areas as well as underserved populations in dense urban areas Novo and its subsidiaries are regulated under the Financial Services Commission of Ontario and accredited through Commission on Accreditation of Rehabilitation Facilities. Compliant treatment, data and administrative protocols are managed through a very senior team of healthcare and administrative professionals. For more information, please visit https://www.novohealthnet.com This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts included in this press release are forward-looking statements. In some cases, forward-looking statements can be identified by words such as “believe,” “expect,” “anticipate,” “plan,” “potential,” “continue” or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks and uncertainties are discussed in TTE’s filings with the Securities and Exchange Commission. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond TTE’s control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects TTE’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. TTE assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The contents of any website referenced in this press release are not incorporated by reference herein.


News Article | May 15, 2017
Site: globenewswire.com

BELLEVUE, Wash., May 15, 2017 (GLOBE NEWSWIRE) -- Turbine Truck Engines, Inc. (OTCQB:TTEG) (“TTE” or the “Company”) announced today that, effective May 9, 2017, Enzo Cirillo has resigned his position as the Company’s Chairman of the Board, a member of the Board of Directors and Interim Chief Executive Officer, Christopher David has resigned his position as the Company’s Secretary and Treasurer and that Judith Norstrud has resigned her position as the Company’s Principal Financial Officer and Principal Accounting Officer. Mr. David retains his responsibilities as the Company’s President and as a member of the Company’s Board of Directors. The Company also announced that the TTE Board of Directors has increased the size of the Company’s Board to three members and appointed Dr. Pierre Dalcourt, D.C. and Mr. Michael Gaynor as directors, effective May 9, 2017. The Company also announced today that, effective May 9, 2017, the TTE Board of Directors has appointed Ms. Klara Radulyne, CPA as the Company’s Principal Financial Officer. Chris David, TTE’s President and a Board Director, stated: “The new Board of Directors wishes to thank Mr. Cirillo and Ms. Norstrud for their valuable contributions to TTE. Since his arrival as the Company’s Interim CEO and Board Chairman in August 2014, Enzo has played a critically important role in strengthening TTE's balance sheet, increasing shareholder value and completing the acquisition of Novo Healthnet Limited.  The newly appointed Board members and PFO provide TTE with exceptional talent and expertise as the Company undertakes implementing the Novo growth model to provide effective and efficient whole health medicine through the integration of healthcare, technology and medical science.” Enzo Cirillo stated: “I am grateful for the support I have received from the shareholders, Board of Directors and management of TTE over the time I have served as TTE’s Interim CEO and Board Chairman. I wish the new team all the best in bringing the Novo comprehensive healthcare and wellness platform to market.” Biographies of each of the new Board members and the new PFO are as follows: As a chiropractic business owner, with a core focus and passion serving the masses with a patient centered model, Dr. Dalcourt has had great success creating scalable businesses and high volume practices combining the wellness approach with sound science. Dr. Dalcourt is a professional health coach and speaker on various stages across North America, as well as a best-selling author having co-written several books on chiropractic, health and self-improvement. In 1994, Dr. Dalcourt graduated Magna Cum Laude from Canadian Memorial Chiropractic College, Toronto, Ontario. He is a certified acupuncturist, having received his certification from the Medecina Alternativa Institute of Sri Lanka. For over 28 years as a healthcare professional and business owner, Mr. Gaynor prides himself on his passion to deliver a healthcare model that includes best practices and innovation to meet various needs for both his community and his patients. At the core of Mr. Gaynor’s mission is building strong relationships, trust, and rapport which cultivates long-term partnerships, alliances, collaboration, forward momentum and positive results. In 1994, Mr. Gaynor founded Back on Track Physiotherapy & Health Centres which has grown into 8 multidisciplinary health and wellness centres of excellence across eastern Ontario. During these 23 years, Mr. Gaynor has proven his capacity to simultaneously practice his healthcare professional trade while also being responsible for business development, marketing and operations. The Back on Track expansion model has been centered on organic business development combined with turnarounds and transitional growth via clinic acquisitions and strategic partnerships. In 2013, Back on Track was acquired by Novo Healthnet Limited (“Novo”). Mr. Gaynor joined the Novo team as managing partner and Chief Operating Officer. Currently, Mr. Gaynor is an integral contributor to Novo’s strategic planning, ongoing growth and business development. In 1989, Mr. Gaynor graduated from Queen’s University in 1989 with a Bachelor of Science in Physical Therapy. Mr. Gaynor has undertaken numerous post graduate studies in a variety of areas including manual therapy, orthopaedics, sports medicine, rehabilitation exercise, acupuncture, as well as practice management and business development, and is committed to the continuing education process. In 1999, as a Fellow of the Canadian Academy Manipulative Physiotherapists (CAMPT), Mr. Gaynor received his Diploma of Advanced Manual & Manipulative Physiotherapy from the Canadian Physiotherapy Association (CPA).  He has been an assistant instructor in post-graduate studies for physiotherapists within the Orthopaedic Division of the CPA and was the former president of the national capital district of the CPA’s orthopaedic division. Klara Radulyne is the Director of Finance for Novo managing all accounting and finance functions. In addition, Ms. Radulyne is TTE’s Principal Financial Officer managing all internal and external reporting functions including process optimization, strategic planning and regulatory compliance. In 2000, Ms. Radulyne acquired her Masters Degree in Accounting and Corporate Valuation from Corvinus University, Budapest, Hungary and immediately commenced her accounting career as a management accountant in a Hungarian utilities industry company. Ms. Radulyne moved to Canada and began her employment with Novo Healthnet Limited in 2006 as a Junior Accountant. Ms. Radulyne earned her Canadian CGA designation in 2010 and Canadian CPA designation in 2014. Since 2000, TTE has been a clean-air technology company dedicated to identifying, developing and commercializing important scientific innovations designed to enhance both environmental conservation and cost savings in how the world produces and consumes energy. With the Novo acquisition, effective May 9, 2017, TTE immediately re-directed all business operations away from the alternative energy sector and now focuses its resources and operations toward executing the Novo growth model to provide effective and efficient whole health medicine through the integration of healthcare, technology and medical science. For more information concerning TTE, please visit www.ttengines.com. Novo is a wholly owned foreign subsidiary of TTE. Novo owns a 100% stake in Novo Assessments, Inc., Novo Healthnet Rehab Limited and Novo Peak Health, Inc., and an 80% stake in Novo Healthnet Kemptville Centre, Inc. (collectively the “Novo Family”) all of which are Ontario province, Canada corporations. The Novo Family operates within the healthcare para-medical services sector. With physical presence in over 350 locations and expanding, the Novo Family’s network provides healthcare treatment and services to more than 350,000 patients annually in clinic, home and institutional environments. Novo’s future growth strategy is centered on expanding patient based healthcare solutions through the integration of healthcare, technology and medical science. Through an advanced virtual physician access system, Novo’s integrated healthcare platform will present patients worldwide with one-center, patient-based healthcare diagnostic and treatment solutions without compromising the traditional primary care physician platform. Novo’s emphasis on providing access to primary care medical solutions through virtual technology allows for centralization of services to occur on a micro footprint level while providing healthcare solutions to remote and small population areas as well as underserved populations in dense urban areas Novo and its subsidiaries are regulated under the Financial Services Commission of Ontario and accredited through Commission on Accreditation of Rehabilitation Facilities. Compliant treatment, data and administrative protocols are managed through a very senior team of healthcare and administrative professionals. For more information, please visit https://www.novohealthnet.com This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts included in this press release are forward-looking statements. In some cases, forward-looking statements can be identified by words such as “believe,” “expect,” “anticipate,” “plan,” “potential,” “continue” or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks and uncertainties are discussed in TTE’s filings with the Securities and Exchange Commission. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond TTE’s control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects TTE’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. TTE assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The contents of any website referenced in this press release are not incorporated by reference herein.


News Article | May 15, 2017
Site: globenewswire.com

BELLEVUE, Wash., May 15, 2017 (GLOBE NEWSWIRE) -- Turbine Truck Engines, Inc. (OTCQB:TTEG) (“TTE” or the “Company”) announced today that, effective May 9, 2017, Enzo Cirillo has resigned his position as the Company’s Chairman of the Board, a member of the Board of Directors and Interim Chief Executive Officer, Christopher David has resigned his position as the Company’s Secretary and Treasurer and that Judith Norstrud has resigned her position as the Company’s Principal Financial Officer and Principal Accounting Officer. Mr. David retains his responsibilities as the Company’s President and as a member of the Company’s Board of Directors. The Company also announced that the TTE Board of Directors has increased the size of the Company’s Board to three members and appointed Dr. Pierre Dalcourt, D.C. and Mr. Michael Gaynor as directors, effective May 9, 2017. The Company also announced today that, effective May 9, 2017, the TTE Board of Directors has appointed Ms. Klara Radulyne, CPA as the Company’s Principal Financial Officer. Chris David, TTE’s President and a Board Director, stated: “The new Board of Directors wishes to thank Mr. Cirillo and Ms. Norstrud for their valuable contributions to TTE. Since his arrival as the Company’s Interim CEO and Board Chairman in August 2014, Enzo has played a critically important role in strengthening TTE's balance sheet, increasing shareholder value and completing the acquisition of Novo Healthnet Limited.  The newly appointed Board members and PFO provide TTE with exceptional talent and expertise as the Company undertakes implementing the Novo growth model to provide effective and efficient whole health medicine through the integration of healthcare, technology and medical science.” Enzo Cirillo stated: “I am grateful for the support I have received from the shareholders, Board of Directors and management of TTE over the time I have served as TTE’s Interim CEO and Board Chairman. I wish the new team all the best in bringing the Novo comprehensive healthcare and wellness platform to market.” Biographies of each of the new Board members and the new PFO are as follows: As a chiropractic business owner, with a core focus and passion serving the masses with a patient centered model, Dr. Dalcourt has had great success creating scalable businesses and high volume practices combining the wellness approach with sound science. Dr. Dalcourt is a professional health coach and speaker on various stages across North America, as well as a best-selling author having co-written several books on chiropractic, health and self-improvement. In 1994, Dr. Dalcourt graduated Magna Cum Laude from Canadian Memorial Chiropractic College, Toronto, Ontario. He is a certified acupuncturist, having received his certification from the Medecina Alternativa Institute of Sri Lanka. For over 28 years as a healthcare professional and business owner, Mr. Gaynor prides himself on his passion to deliver a healthcare model that includes best practices and innovation to meet various needs for both his community and his patients. At the core of Mr. Gaynor’s mission is building strong relationships, trust, and rapport which cultivates long-term partnerships, alliances, collaboration, forward momentum and positive results. In 1994, Mr. Gaynor founded Back on Track Physiotherapy & Health Centres which has grown into 8 multidisciplinary health and wellness centres of excellence across eastern Ontario. During these 23 years, Mr. Gaynor has proven his capacity to simultaneously practice his healthcare professional trade while also being responsible for business development, marketing and operations. The Back on Track expansion model has been centered on organic business development combined with turnarounds and transitional growth via clinic acquisitions and strategic partnerships. In 2013, Back on Track was acquired by Novo Healthnet Limited (“Novo”). Mr. Gaynor joined the Novo team as managing partner and Chief Operating Officer. Currently, Mr. Gaynor is an integral contributor to Novo’s strategic planning, ongoing growth and business development. In 1989, Mr. Gaynor graduated from Queen’s University in 1989 with a Bachelor of Science in Physical Therapy. Mr. Gaynor has undertaken numerous post graduate studies in a variety of areas including manual therapy, orthopaedics, sports medicine, rehabilitation exercise, acupuncture, as well as practice management and business development, and is committed to the continuing education process. In 1999, as a Fellow of the Canadian Academy Manipulative Physiotherapists (CAMPT), Mr. Gaynor received his Diploma of Advanced Manual & Manipulative Physiotherapy from the Canadian Physiotherapy Association (CPA).  He has been an assistant instructor in post-graduate studies for physiotherapists within the Orthopaedic Division of the CPA and was the former president of the national capital district of the CPA’s orthopaedic division. Klara Radulyne is the Director of Finance for Novo managing all accounting and finance functions. In addition, Ms. Radulyne is TTE’s Principal Financial Officer managing all internal and external reporting functions including process optimization, strategic planning and regulatory compliance. In 2000, Ms. Radulyne acquired her Masters Degree in Accounting and Corporate Valuation from Corvinus University, Budapest, Hungary and immediately commenced her accounting career as a management accountant in a Hungarian utilities industry company. Ms. Radulyne moved to Canada and began her employment with Novo Healthnet Limited in 2006 as a Junior Accountant. Ms. Radulyne earned her Canadian CGA designation in 2010 and Canadian CPA designation in 2014. Since 2000, TTE has been a clean-air technology company dedicated to identifying, developing and commercializing important scientific innovations designed to enhance both environmental conservation and cost savings in how the world produces and consumes energy. With the Novo acquisition, effective May 9, 2017, TTE immediately re-directed all business operations away from the alternative energy sector and now focuses its resources and operations toward executing the Novo growth model to provide effective and efficient whole health medicine through the integration of healthcare, technology and medical science. For more information concerning TTE, please visit www.ttengines.com. Novo is a wholly owned foreign subsidiary of TTE. Novo owns a 100% stake in Novo Assessments, Inc., Novo Healthnet Rehab Limited and Novo Peak Health, Inc., and an 80% stake in Novo Healthnet Kemptville Centre, Inc. (collectively the “Novo Family”) all of which are Ontario province, Canada corporations. The Novo Family operates within the healthcare para-medical services sector. With physical presence in over 350 locations and expanding, the Novo Family’s network provides healthcare treatment and services to more than 350,000 patients annually in clinic, home and institutional environments. Novo’s future growth strategy is centered on expanding patient based healthcare solutions through the integration of healthcare, technology and medical science. Through an advanced virtual physician access system, Novo’s integrated healthcare platform will present patients worldwide with one-center, patient-based healthcare diagnostic and treatment solutions without compromising the traditional primary care physician platform. Novo’s emphasis on providing access to primary care medical solutions through virtual technology allows for centralization of services to occur on a micro footprint level while providing healthcare solutions to remote and small population areas as well as underserved populations in dense urban areas Novo and its subsidiaries are regulated under the Financial Services Commission of Ontario and accredited through Commission on Accreditation of Rehabilitation Facilities. Compliant treatment, data and administrative protocols are managed through a very senior team of healthcare and administrative professionals. For more information, please visit https://www.novohealthnet.com This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts included in this press release are forward-looking statements. In some cases, forward-looking statements can be identified by words such as “believe,” “expect,” “anticipate,” “plan,” “potential,” “continue” or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks and uncertainties are discussed in TTE’s filings with the Securities and Exchange Commission. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond TTE’s control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects TTE’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. TTE assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The contents of any website referenced in this press release are not incorporated by reference herein.


Patent
Canadian Memorial Chiropractic College | Date: 2016-10-20

Described herein are various embodiments of a manipulative treatment training system and method to provide constructive feedback to candidates practicing selected training actions on a mannequin to learn or improve certain treatment methods and techniques, and thus, thereafter provide more accurate and/or safe treatment to patients.


Howarth S.J.,Canadian Memorial Chiropractic College | Callaghan J.P.,University of Waterloo
Journal of Biomechanics | Year: 2012

Despite the findings that peak anterior shear load is highly correlated with low-back pain reporting, very little research has been conducted to determine how vertebral shear injury potential is influenced. The current study quantified the combined effects of vertebral joint compression and flexion/extension postural deviation from neutral on ultimate shear failure. Ninety-six porcine cervical specimens (48C3-C4, 48C5-C6) were tested. Each specimen was randomly assigned to one of twelve combinations of compressive force (15%, 30%, 45%, or 60% of predicted compressive failure force) and flexion/extension postural deviation (extended, neutral, or flexed). Vertebral joint shear failure was induced by applying posterior shear displacement of the caudal vertebra at a constant rate of 0.15. mm/s. Throughout shear failure tests, vertebral joint kinematics were measured using an optoelectronic camera and a series of infrared light emitting diodes while shear force was measured from load cells rigidly interfaced in series with linear actuators that applied the shear displacement. Measurements of shear stiffness, ultimate force, displacement, and energy stored were made from the force-displacement data. Compressive force and postural deviation demonstrated main effects without a statistically significant interaction for any of the measurements. Shear failure force increased by 11.1% for each 15% increment in compressive force (p<0.05). Postural deviation from neutral impacted ultimate shear failure force by a 12.8% increase with extension (p<0.05) and a 13.2% decrease with flexion (p<0.05). Displacement at ultimate failure was not significantly altered by either compressive force or postural deviation. These results demonstrate that shear failure force may be governed by changes in facet articulation, either by postural deviation or by reducing vertebral joint height through compression that alter the moment arm length between the center of facet contact pressure and the pars interarticularis location. However, objective evidence of this alteration currently does not exist. Both compression and flexion/extension postural deviation should be equally considered while assessing shear injury potential. © 2011 Elsevier Ltd.


Lejkowski P.M.,Canadian Memorial Chiropractic College | Poulsen E.,Nordic Institute of Chiropractic and Clinical Biomechanics
Journal of Bodywork and Movement Therapies | Year: 2013

Background: The biomechanical relationship between the hip and low back is well described and impairment of hip range of motion is thought to affect lumbar spine function, possibly leading to increased loading and subsequent symptoms. However therapy for low back pain (LBP) patients is commonly directed solely to the low back area overlooking possible hip impairment. Case description: A 56-year-old male recreational golfer presented with a chronic golf-related low back complaint. Previous conservative therapy targeting the spine did not result in complete symptom relief. A working diagnosis of L4-S1 facet joint irritation and lower lumbar segmental instability secondary to bilateral hip ROM impairment was established. A trial of therapy strictly addressing the hip ROM impairments was initiated and following 2 treatment sessions, a complete resolution of symptoms was achieved and maintained at a 2-month follow-up. Discussion: This case demonstrated a complete and rapid relief of un-resolving low back pain with a management strategy focused on hip ROM impairments. Clinicians should remember to look beyond the local area of complaint and appreciate the interdependent nature of the musculoskeletal system. © 2013 Elsevier Ltd.


Objectives: To investigate the effects of topical agents for the treatment of Myofascial Pain Syndrome (MPS) and Myofascial Trigger Point (MTRP).Methods: Subjects with an identifiable trigger point in the trapezius muscle, age 18-80 were recruited for a single-session randomized, placebo-blinded clinical study. Baseline measurements of trapezius muscle pressure pain threshold (PPT: by pressure algometer) along with right and left cervical lateral flexion (rangiometer) were obtained by a blinded examiner. An assessor blinded to the outcomes assessments applied one of 6 topical formulations which had been placed in identical plastic containers. Five of these topicals were proposed active formulations; the control group was given a non-active formulation (PLA). Five minutes after the application of the formula the outcome measures were re-tested. Data were analyzed with a 5-way ANOVA and Holms-adjusted t-tests with an alpha level of 0.05.Results: 120 subjects were entered into the study (63 females; ages 16-82); 20 subjects randomly allocated into each group. The pre- and post-treatment results for pressure threshold did show significant intra-group increases for the Ben-Gay Ultra Strength Muscle Pain Ointment (BG), the Professional Therapy MuscleCare Roll-on (PTMC roll-on) and Motion Medicine Cream (MM) with an increased threshold of 0.5 kg/cm2(+/-0.15), 0.72 kg/cm2(+/-0.17) and 0.47 Kg/cm2(+/-0.19) respectively. With respect to the inter-group comparisons, PTMC roll-on showed significant increases in pressure threshold compared with Placebo (PLA) (p = 0.002) and Icy Hot Extra Strength Cream (IH) (p = 0.006). In addition, BG demonstrated significant increases in pressure threshold compared with PLA (p = 0.0003).Conclusions: With regards to pressure threshold, PTMC roll-on, BG and MM showed significant increases in pain threshold tolerance after a short-term application on a trigger points located in the trapezius muscle. PTMC roll-on and BG were both shown to be superior vs placebo while PTMC was also shown to be superior to IH in patients with trigger points located in the trapezius muscle on a single application.CMCC Research Ethics Board Approval # 1012X01, 2011. © 2012 Avrahami et al; licensee BioMed Central Ltd.


Vernon H.,Canadian Memorial Chiropractic College
Chiropractic and Manual Therapies | Year: 2012

Background: The mechanisms subserving deep spinal pain have not been studied as well as those related to the skin and to deep pain in peripheral limb structures. The clinical phenomenology of deep spinal pain presents unique features which call for investigations which can explain these at a mechanistic level.Methods: Targeted searches of the literature were conducted and the relevant materials reviewed for applicability to the thesis that deep spinal pain is distinctive from deep pain in the peripheral limb structures. Topics related to the neuroanatomy and neurophysiology of deep spinal pain were organized in a hierarchical format for content review.Results: Since the 1980's the innervation characteristics of the spinal joints and deep muscles have been elucidated. Afferent connections subserving pain have been identified in a distinctive somatotopic organization within the spinal cord whereby afferents from deep spinal tissues terminate primarily in the lateral dorsal horn while those from deep peripheral tissues terminate primarily in the medial dorsal horn. Mechanisms underlying the clinical phenomena of referred pain from the spine, poor localization of spinal pain and chronicity of spine pain have emerged from the literature and are reviewed here, especially emphasizing the somatotopic organization and hyperconvergence of dorsal horn " low back (spinal) neurons" . Taken together, these findings provide preliminary support for the hypothesis that deep spine pain is different from deep pain arising from peripheral limb structures.Conclusions: This thesis addressed the question " what is different about spine pain?" Neuroanatomic and neurophysiologic findings from studies in the last twenty years provide preliminary support for the thesis that deep spine pain is different from deep pain arising from peripheral limb structures. © 2012 Vernon; lisencee BioMed Central Ltd.


Budgell B.S.,Canadian Memorial Chiropractic College
Journal of Chinese Integrative Medicine | Year: 2013

Biomedical language, also known as biomedical English, is sufficiently different from general English to warrant treatment as a distinct language. Biomedical language has its own conventions of grammar, phraseology and discourse, as well as a lexicon which is complex and esoteric. Furthermore, each sub-discipline, such as integrative medicine, has a unique vocabulary which must be mastered in order to achieve fluency. In this article, the vocabulary specific to acupuncture is identified, and strategies are introduced to master the use of that vocabulary. © 2013 Brian Stephen Budgell.


Kazemi M.,Canadian Memorial Chiropractic College
Journal of Sports Sciences | Year: 2012

The purpose of this study was to determine the rate and type of injury in elite Canadian Taekwondo athletes, before and during competition and to investigate the relationship between past injuries, injuries during competition and success. This retrospective case-series study incorporated Taekwondo injuries sustained by 75 male and female elite Canadian Taekwondo athletes over 10 years and its relationship to athletes' success by means of gaining medals during competition. A logistic regression model (using the Generalised Estimating Equations (GEE) method) was used to investigate the relationship between injuries and success. Injury rate was associated with performance after holding variables constant (Odds Ratio (OR)1/40.124, P1/40.039). Moreover, with each additional injury per match, competitors were 88% (1-0.124) less likely to win a medal. Although not statistically significant, additional injuries prior to competition were associated with a 30% increase in medal prevalence (OR1/41.299, P1/40.203). When comparing athletes (gender, tournament difficulty, injury variables), a competitor who is one year older is 10% less likely to medal (OR1/40.897, P1/40.068). When an additional injury occurred during competition, the athlete was 88% less likely to win a medal. Prevention, correct diagnosis, and immediate therapeutic intervention by qualified health care providers are important. © 2012 Taylor & Francis.

Loading Canadian Memorial Chiropractic College collaborators
Loading Canadian Memorial Chiropractic College collaborators